Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Gandara

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trialD R Gandara, E Vokes, M Green, et al.
The Cancer Journal From Scientific American|May 1, 1997
Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasoneP J Hesketh, D R Gandara, A M Hesketh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1991
Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: results of a phase I/II studyD R Gandara, F H Valone, E A Perez, et al.
Investigational New Drugs|September 18, 1998
Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapyM J Edelman, D R Gandara, E A Perez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignanciesF H Valone, D R Gandara, J A Luce, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology GroupD R Gandara, E A Perez, H Wold, et al.
Investigational New Drugs|August 25, 2000
A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413)J S Macdonald, J L Jacobson, M Modiano, et al.
Seminars in Oncology|March 1, 1986
Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology GroupD R Gandara, H G Wold, J Redmond, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blastsD R Gandara, C A Ries, S A Schiff, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 1, 1991
Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomasF H Valone, D R Gandara, A B Deisseroth, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trialD R Gandara, E Vokes, M Green, et al.
The Cancer Journal From Scientific American|May 1, 1997
Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasoneP J Hesketh, D R Gandara, A M Hesketh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1991
Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: results of a phase I/II studyD R Gandara, F H Valone, E A Perez, et al.
Investigational New Drugs|September 18, 1998
Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapyM J Edelman, D R Gandara, E A Perez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I trial of a 5-day infusion of L-leucovorin plus daily bolus 5-fluorouracil in patients with advanced gastrointestinal malignanciesF H Valone, D R Gandara, J A Luce, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology GroupD R Gandara, E A Perez, H Wold, et al.
Investigational New Drugs|August 25, 2000
A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413)J S Macdonald, J L Jacobson, M Modiano, et al.
Seminars in Oncology|March 1, 1986
Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology GroupD R Gandara, H G Wold, J Redmond, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blastsD R Gandara, C A Ries, S A Schiff, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 1, 1991
Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomasF H Valone, D R Gandara, A B Deisseroth, et al.
Pageof 9